<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Internal Medicine: Psychiatry Topic Collection</title>
    <link>http://archinte.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 15 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 14 May 2013 18:46:50 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archinte.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archinte.jamanetwork.com</webMaster>
    <item>
      <title>Improving Health Care After Prison  Comment on “Forced Smoking Abstinence: Not Enough for Smoking Cessation” Improving Health Care After Prison </title>
      <link>http://archinte.jamanetwork.com/article.aspx?articleID=1675883</link>
      <pubDate>Mon, 13 May 2013 00:00:00 GMT</pubDate>
      <author>Puisis M. </author>
      <description>&lt;span class="paragraphSection"&gt;About 2.3 million people are incarcerated in federal and state prisons and local jails. Annually, 700 000 are discharged from state and federal prisons, and almost 12 million are discharged from local jails. Although prisoners have a constitutional right to medical care, no such right exists once they are discharged. Given that prisoners have a high rate of mental illness, substance abuse, and disease infections, including with human immunodeficiency virus (HIV), hepatitis C, and tuberculosis, their health care once they are discharged is of great public health significance.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">173</prism:volume>
      <prism:number xmlns:prism="prism">9</prism:number>
      <prism:startingPage xmlns:prism="prism">795</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">796</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamainternmed.2013.371</prism:doi>
      <guid>http://archinte.jamanetwork.com/article.aspx?articleID=1675883</guid>
    </item>
    <item>
      <title>Serotonin Reuptake Inhibitor Use, Depression, and Long-Term Outcomes After an Acute Coronary Syndrome: A Prospective Cohort Study</title>
      <link>http://archinte.jamanetwork.com/article.aspx?articleID=1687523</link>
      <pubDate>Mon, 13 May 2013 00:00:00 GMT</pubDate>
      <author>Rieckmann N, Kronish IM, Shapiro PA, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;Depression is highly prevalent among patients with coronary heart disease. Selective serotonin reuptake inhibitors (SSRIs) are recommended as first-line antidepressant treatments for this population. Whereas there is a long-standing notion that SSRIs may improve cardiac disease prognosis by inhibiting platelet aggregation, SSRI use may also worsen prognosis by increasing bleeding or increasing the risk for arrhythmia.&lt;/span&gt;</description>
      <prism:startingPage xmlns:prism="prism">1</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jamainternmed.2013.910</prism:doi>
      <guid>http://archinte.jamanetwork.com/article.aspx?articleID=1687523</guid>
    </item>
  </channel>
</rss>